Examining the impact of hormone therapy and Alzheimer’s disease risk factors on depressive symptoms in the Harvard Aging Brain Study

Documenti analoghi

• Response to – Counteracting white matter injury to mitigate APOE4‐related ARIA
  di: Zahra Shirzadi, et al.
  Pubblicazione: (2026)
• BrainAge moderates associations between AD biomarkers and cognitive decline: findings from A4/LEARN and the Harvard Aging Brain Study
  di: Jorge Garcia Condado, et al.
  Pubblicazione: (2025)
• Left frontoparietal control network connectivity moderates the effect of amyloid on cognitive decline in preclinical Alzheimer’s disease
  di: Rory Boyle, et al.
  Pubblicazione: (2024)
• Sex, menopause, and hormone therapy moderate the PET tau and Aβ association in cognitively unimpaired adults with Down Syndrome: Findings from the Alzheimer Biomarkers Consortium — Down Syndrome
  di: Gillian T Coughlan, et al.
  Pubblicazione: (2024)
• Relationship between Polygenetic Risk Score of BrainAge and plasma biomarkers in the A4/LEARN studies
  di: Jorge Garcia Condado, et al.
  Pubblicazione: (2025)